Eupraxia Pharmaceuticals ... (EPRX)
3.08
0.03 (0.98%)
At close: Jan 15, 2025, 3:58 PM
3.08
0.00%
After-hours Jan 15, 2025, 03:59 PM EST
Company Description
No Company description available at the moment.
Eupraxia Pharmaceuticals Inc.
| Country | n/a |
| IPO Date | n/a |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 29 |
| CEO | Dr. James A. Helliwell FRCPC, M.D. |
Contact Details
Address: No Address available No city data available, | |
| Website | n/a |
Stock Details
| Ticker Symbol | n/a |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | CA29842P1053 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Dr. James A. Helliwell FRCPC, M.D. | Chief Executive Officer & Director |
| Bruce G. Cousins C.A., CPA | President & Chief Financial Officer |
| Dr. Amanda Malone Ph.D. | Chief Scientific Officer & Chief Operating Officer |
| Dr. Mark M. Kowalski M.D., Ph.D. | Chief Medical Officer |
| Dr. Rahul Sarugaser M.B.A., Ph.D. | Executive Vice President of Corporate Development |
| Paul Anthony Brennan B.Sc., M.Sc. | Chief Business Officer |